Firm-fixed-priced purchase order for biopticon tumorimager 2 and tumormanger software.
Ended Purchase Order Awarded
- Contract number
- 75N91021P00501
- Awardee
-
Biopticon Corporation UEI W8JELPX2UZB3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,500
Award facts
- Opportunity
-
- 75N91021Q00069A Solicitation number
- Contract value 100% obligated
- $38,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Princeton, NJ, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N91021P00501?
75N91021P00501 was awarded to Biopticon Corporation by National Cancer Institute (National Institutes of Health) on August 2, 2021.
How much is contract 75N91021P00501 worth?
The government has obligated $38,500 on 75N91021P00501.
Was contract 75N91021P00501 competed?
The extent of competition for 75N91021P00501 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award